Spots Global Cancer Trial Database for Study of IV Edotecarin Vs Temozolomide or Carmustine (BCNU) or Lomustine (CCNU) in Patients With Glioblastoma Multiforme
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study of IV Edotecarin Vs Temozolomide or Carmustine (BCNU) or Lomustine (CCNU) in Patients With Glioblastoma Multiforme
Official Title: A Phase III, Randomized, Open-Label Study Of IV Edotecarin Vs Temozolomide Or Carmustine (BCNU) Or Lomustine (CCNU) In Patients With Glioblastoma Multiforme At First Relapse After Alkylator-Based (NEO) Adjuvant Chemotherapy
Study ID: NCT00068952
Conditions
Study Description
Brief Summary: The purpose of this clinical trial is to study Edotecarin in patients with the brain tumor glioblastoma multiforme (GBM) who have progression or first recurrence following initial treatment with surgery, radiation and chemotherapy.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Pfizer Investigational Site, Phoenix, Arizona, United States
Pfizer Investigational Site, Little Rock, Arkansas, United States
Pfizer Investigational Site, New Haven, Connecticut, United States
Pfizer Investigational Site, Orlando, Florida, United States
Pfizer Investigational Site, Atlanta, Georgia, United States
Pfizer Investigational Site, Chicago, Illinois, United States
Pfizer Investigational Site, Evanston, Illinois, United States
Pfizer Investigational Site, Edgewood, Kentucky, United States
Pfizer Investigational Site, Edgweood, Kentucky, United States
Pfizer Investigational Site, Lexington, Kentucky, United States
Pfizer Investigational Site, Boston, Massachusetts, United States
Pfizer Investigational Site, Lebanon, New Hampshire, United States
Pfizer Investigational Site, Edison, New Jersey, United States
Pfizer Investigational Site, Summit, New Jersey, United States
Pfizer Investigational Site, Cincinnati, Ohio, United States
Pfizer Investigational Site, Philadelphia, Pennsylvania, United States
Pfizer Investigational Site, Pittsburgh, Pennsylvania, United States
Pfizer Investigational Site, Dallas, Texas, United States
Pfizer Investigational Site, Charlottesville, Virginia, United States
Pfizer Investigational Site, St. Leonards, New South Wales, Australia
Pfizer Investigational Site, East Bentleigh, Victoria, Australia
Pfizer Investigational Site, Clayton, , Australia
Pfizer Investigational Site, Graz, , Austria
Pfizer Investigational Site, Wien, , Austria
Pfizer Investigational Site, Calgary, Alberta, Canada
Pfizer Investigational Site, Vancouver, British Columbia, Canada
Pfizer Investigational Site, Winnipeg, Manitoba, Canada
Pfizer Investigational Site, Moncton, New Brunswick, Canada
Pfizer Investigational Site, Halifax, Nova Scotia, Canada
Pfizer Investigational Site, Hamilton, Ontario, Canada
Pfizer Investigational Site, Ottawa, Ontario, Canada
Pfizer Investigational Site, Toronto, Ontario, Canada
Pfizer Investigational Site, Split, , Croatia
Pfizer Investigational Site, Zagreb, , Croatia
Pfizer Investigational Site, Hradec Kralove, , Czech Republic
Pfizer Investigational Site, Praha 5, , Czech Republic
Pfizer Investigational Site, Lyon, , France
Pfizer Investigational Site, Nantes St. Herblain, , France
Pfizer Investigational Site, Berlin, , Germany
Pfizer Investigational Site, Mainz, , Germany
Pfizer Investigational Site, Regensburg, , Germany
Pfizer Investigational Site, Tuebingen, , Germany
Pfizer Investigational Site, Bangalore, , India
Pfizer Investigational Site, Bologna, , Italy
Pfizer Investigational Site, Padova, , Italy
Pfizer Investigational Site, Moscow, , Russian Federation
Pfizer Investigational Site, Cape Town, , South Africa
Pfizer Investigational Site, Pretoria, , South Africa
Pfizer Investigational Site, Badalona, , Spain
Pfizer Investigational Site, Hospitalet de Llobregat, , Spain
Pfizer Investigational Site, Oviedo, , Spain
Pfizer Investigational Site, , ,
Contact Details
Name: Pfizer CT.gov Call Center
Affiliation: Pfizer
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
